CStone Pharmaceuticals Co. Ltd.
http://www.cstonepharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From CStone Pharmaceuticals Co. Ltd.
Shanghai Reopens, Beijing Offers Policy Relief As Pharma Embraces Uncertain Future
China’s largest commercial center and pharma industry hub reopens after over two months of strict lockdown.
Younger Females' Cancer Incidence Increases Significantly In China
Latest data show a worrying public health trend that remains the top health concern in China despite surging COVID infections.
Finance Watch: Financial Market Turmoil Ends Amicus SPAC Deal For Gene Therapy Spinout
Public Company Edition: As their stock prices plummet, Adagio reshuffles its research plan and names a new CEO, while Yumanity restructures and seeks strategic alternatives. Also, Bristol sells $6bn worth of notes, Amgen issues $750m green bond, and Inhibrx and Amryt amend and refinance debt.
Lilly/Innovent Experience Show Hurdles Remaining For Chinese PD-1 Inhibitors
China has fielded several homegrown checkpoint inhibitors, using lower cost as an argument for the US market, but sintilimab – a key test case – has underscored FDA skepticism.